Stanojković, T.

Link to this page

Authority KeyName Variants
be7283b7-57f3-4b80-bbd2-84f86e9befef
  • Stanojković, T. (2)
Projects

Author's Bibliography

PO-410 Cytotoxicity and genotoxicity of new gadolinium, iron oxide, cobalt ferrite and graphene oxide nanoparticles on some tumour cell lines in vitro

Zizak, I. Besu; Zizak, B.; Janović, Barbara; Vujčić, Miroslava; Jokanović, Vukoman; Babić-Stojić, B.; Čolović, B.; Vujčić, Zoran; Stanojković, T.

(Elsevier, 2018)

TY  - CONF
AU  - Zizak, I. Besu
AU  - Zizak, B.
AU  - Janović, Barbara
AU  - Vujčić, Miroslava
AU  - Jokanović, Vukoman
AU  - Babić-Stojić, B.
AU  - Čolović, B.
AU  - Vujčić, Zoran
AU  - Stanojković, T.
PY  - 2018
UR  - https://cer.ihtm.bg.ac.rs/handle/123456789/4673
AB  - Nanoparticles (NPs) are increasingly used in cancer
therapy as delivery agents and in the diagnosis of malignant diseases
as contrast agents for magnetic resonance imaging (MRI).
The aim of this work was in vitro assessments of Gd-NPs, Fe-
NPs, CoFe-NPs and Graphene Oxide-NPs cytotoxicity and genotoxicity
on some tumour and normal human cell lines.
PB  - Elsevier
C3  - ESMO Open
T1  - PO-410 Cytotoxicity and genotoxicity of new gadolinium, iron oxide, cobalt ferrite and graphene oxide nanoparticles on some tumour cell lines in vitro
VL  - 3
IS  - Suppl 2
SP  - A183
DO  - 10.1136/esmoopen-2018-EACR25.436
ER  - 
@conference{
author = "Zizak, I. Besu and Zizak, B. and Janović, Barbara and Vujčić, Miroslava and Jokanović, Vukoman and Babić-Stojić, B. and Čolović, B. and Vujčić, Zoran and Stanojković, T.",
year = "2018",
abstract = "Nanoparticles (NPs) are increasingly used in cancer
therapy as delivery agents and in the diagnosis of malignant diseases
as contrast agents for magnetic resonance imaging (MRI).
The aim of this work was in vitro assessments of Gd-NPs, Fe-
NPs, CoFe-NPs and Graphene Oxide-NPs cytotoxicity and genotoxicity
on some tumour and normal human cell lines.",
publisher = "Elsevier",
journal = "ESMO Open",
title = "PO-410 Cytotoxicity and genotoxicity of new gadolinium, iron oxide, cobalt ferrite and graphene oxide nanoparticles on some tumour cell lines in vitro",
volume = "3",
number = "Suppl 2",
pages = "A183",
doi = "10.1136/esmoopen-2018-EACR25.436"
}
Zizak, I. B., Zizak, B., Janović, B., Vujčić, M., Jokanović, V., Babić-Stojić, B., Čolović, B., Vujčić, Z.,& Stanojković, T.. (2018). PO-410 Cytotoxicity and genotoxicity of new gadolinium, iron oxide, cobalt ferrite and graphene oxide nanoparticles on some tumour cell lines in vitro. in ESMO Open
Elsevier., 3(Suppl 2), A183.
https://doi.org/10.1136/esmoopen-2018-EACR25.436
Zizak IB, Zizak B, Janović B, Vujčić M, Jokanović V, Babić-Stojić B, Čolović B, Vujčić Z, Stanojković T. PO-410 Cytotoxicity and genotoxicity of new gadolinium, iron oxide, cobalt ferrite and graphene oxide nanoparticles on some tumour cell lines in vitro. in ESMO Open. 2018;3(Suppl 2):A183.
doi:10.1136/esmoopen-2018-EACR25.436 .
Zizak, I. Besu, Zizak, B., Janović, Barbara, Vujčić, Miroslava, Jokanović, Vukoman, Babić-Stojić, B., Čolović, B., Vujčić, Zoran, Stanojković, T., "PO-410 Cytotoxicity and genotoxicity of new gadolinium, iron oxide, cobalt ferrite and graphene oxide nanoparticles on some tumour cell lines in vitro" in ESMO Open, 3, no. Suppl 2 (2018):A183,
https://doi.org/10.1136/esmoopen-2018-EACR25.436 . .
1

PO-129 In vitro radiosensitivity and repair kinetics of PBMCs from prostate cancer patients and healthy donors evaluated by comet assay

Zizak, Z.; Janović, Barbara; Zizak, I.Besu; Vujčić, Z.; Stanković, Vesna; Matić, I.; Nikitović, M.; Stanojković, T.

(Elsevier, 2018)

TY  - CONF
AU  - Zizak, Z.
AU  - Janović, Barbara
AU  - Zizak, I.Besu
AU  - Vujčić, Z.
AU  - Stanković, Vesna
AU  - Matić, I.
AU  - Nikitović, M.
AU  - Stanojković, T.
PY  - 2018
UR  - https://cer.ihtm.bg.ac.rs/handle/123456789/4674
AB  - A high cellular radiosensitivity is connected with a risk for development of severe side effects after radiotherapy. In this study we have attempted to find a correlation between the initial radiosensitivity of in vitro irradiated peripheral blood mononuclear cells (PBMC) of prostate cancer patients and the adverse side effects of radiotherapy.
PB  - Elsevier
C3  - ESMO Open
T1  - PO-129 In vitro radiosensitivity and repair kinetics of PBMCs from prostate cancer patients and healthy donors evaluated by comet assay
VL  - 3
IS  - Sup.2
SP  - A276
EP  - A277
DO  - 10.1136/esmoopen-2018-EACR25.653
ER  - 
@conference{
author = "Zizak, Z. and Janović, Barbara and Zizak, I.Besu and Vujčić, Z. and Stanković, Vesna and Matić, I. and Nikitović, M. and Stanojković, T.",
year = "2018",
abstract = "A high cellular radiosensitivity is connected with a risk for development of severe side effects after radiotherapy. In this study we have attempted to find a correlation between the initial radiosensitivity of in vitro irradiated peripheral blood mononuclear cells (PBMC) of prostate cancer patients and the adverse side effects of radiotherapy.",
publisher = "Elsevier",
journal = "ESMO Open",
title = "PO-129 In vitro radiosensitivity and repair kinetics of PBMCs from prostate cancer patients and healthy donors evaluated by comet assay",
volume = "3",
number = "Sup.2",
pages = "A276-A277",
doi = "10.1136/esmoopen-2018-EACR25.653"
}
Zizak, Z., Janović, B., Zizak, I.Besu, Vujčić, Z., Stanković, V., Matić, I., Nikitović, M.,& Stanojković, T.. (2018). PO-129 In vitro radiosensitivity and repair kinetics of PBMCs from prostate cancer patients and healthy donors evaluated by comet assay. in ESMO Open
Elsevier., 3(Sup.2), A276-A277.
https://doi.org/10.1136/esmoopen-2018-EACR25.653
Zizak Z, Janović B, Zizak I, Vujčić Z, Stanković V, Matić I, Nikitović M, Stanojković T. PO-129 In vitro radiosensitivity and repair kinetics of PBMCs from prostate cancer patients and healthy donors evaluated by comet assay. in ESMO Open. 2018;3(Sup.2):A276-A277.
doi:10.1136/esmoopen-2018-EACR25.653 .
Zizak, Z., Janović, Barbara, Zizak, I.Besu, Vujčić, Z., Stanković, Vesna, Matić, I., Nikitović, M., Stanojković, T., "PO-129 In vitro radiosensitivity and repair kinetics of PBMCs from prostate cancer patients and healthy donors evaluated by comet assay" in ESMO Open, 3, no. Sup.2 (2018):A276-A277,
https://doi.org/10.1136/esmoopen-2018-EACR25.653 . .